BRCR Global - San Juan, PR

Research site

Location

29 Washington Street Suite 310, San Juan, Puerto Rico, United States of America

Site insights

Top conditions

Top treatments

Ferric Maltol

Pertuzumab

LY3502970

Ritonavir

Iron

Ferrous Sulfate

DB-1305

Itraconazole

Levothyroxine

Parent organization

This site is a part of BRCR Global

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Patricia Gonzalez

Verified by this site

Active trials

5 of 8 total trials

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced sol...

Enrolling

HER2-positive Advanced Solid Tumor

Drug: Itraconazole

Biological: DB-1303/BNT323

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism a...

Enrolling

Hypothyroidism

Drug: Levothyroxine

Drug: Armour Thyroid

Status recently updated

A Study to Learn About How a New Pneumococcal Vaccine Works in Children

The purpose of this study is to learn about the safety, tolerability and immune effects of a pneumococcal vaccine in toddlers.Participants will take...

Enrolling

Active, not recruiting

Pneumococcal Disease

Biological: 20-valent pneumococcal conjugate vaccine (20vPnC)

Biological: PG4

A Study to Learn About How a New Pneumococcal Vaccine Works in Infants

The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germ...

Enrolling

Pneumococcal Disease

Biological: 15-valent pneumococcal conjugate vaccine (PCV15)

Biological: PG4

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1305/BNT325 in subjects with advanced sol...

Enrolling

Advanced Solid Tumor

Drug: DB-1305/BNT325

Drug: BNT327